tiprankstipranks
Cytek Biosciences (CTKB)
NASDAQ:CTKB
US Market

Cytek Biosciences (CTKB) Income Statement

Compare
52 Followers

Cytek Biosciences Income Statement

Last quarter (Q3 2024), Cytek Biosciences's total revenue was $51.50M, an increase of 7.29% from the same quarter last year. In Q3, Cytek Biosciences's net income was $941.00K. See Cytek Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 193.01M$ 164.04M$ 127.95M$ 92.84M$ 57.88M
Gross Profit
$ 109.43M$ 100.97M$ 79.14M$ 51.71M$ 28.67M
Operating Expenses
$ 137.27M$ 102.78M$ 69.98M$ 38.05M$ 25.91M
Depreciation and Amortization
$ 9.23M$ 5.70M$ 1.24M$ 603.00K$ 309.00K
EBITDA
$ -4.41M$ 9.54M$ 10.40M$ 15.37M$ -15.98M
Operating Income
$ -27.84M$ -1.83M$ 6.45M$ 13.66M$ 3.73M
Other Income/Expenses
$ 12.14M$ 3.06M$ -3.22M$ 771.00K$ 962.00K
Pretax Income
$ -15.71M$ 1.26M$ 5.95M$ 14.43M$ -16.29M
Net Income
$ -12.15M$ 2.58M$ 4.42M$ 19.41M$ -16.83M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.09$ 0.02$ 0.03$ 0.02$ -0.13
Diluted EPS
$ -0.09$ 0.02$ 0.03$ 0.02$ -0.13
Weighted Average Shares Outstanding
135.28M 134.51M 133.75M 132.99M 132.99M
Weighted Average Shares Outstanding (Diluted)
135.28M 138.56M 133.75M 132.99M 132.99M
Currency in USD

Cytek Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis